ET-1 appears to mediate endothelial dysfunction by reducing NO bioavailability both through its interference with the expression and activity of endothelial NO synthase [22], and the formation of reactive oxygen species [23–25]. The gene discussed is EDN1; the disease is endothelial dysfunction.